ArticleCureus2025
Trends and Economic Implications of Operative Management for Pediatric Forearm Fractures: A Retrospective Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPediatric forearm fractures are traditionally managed conservatively with satisfactory results. However, operative management is trending upward without definitive evidence of superior outcomes. This investigation aims to evaluate trends in the operative management of acute pediatric forearm fractures globally and to estimate the cost of treatment to ascertain management preferences and guidance.
methodsA retrospective cohort analysis of the TriNetX database (TriNetX, Cambridge, MA, USA) was performed by querying all pediatric patients (ages one to 21) who underwent treatment for radial and ulnar shaft forearm fractures between 2014 and 2024 (n = 30,449). The operatively managed cohort included the percentage of patients who received open treatment (current procedural terminology (CPT): 25575 and/or 25574) each year while the conservatively managed cohort featured patients who received closed treatment (CPT: 25560 and/or 25565) each year. Incidence data for 2024, up to September 4th, was extracted but not included in the trend analysis due to its incomplete representation of the full year. The annual Medicare-designated relative value units and reimbursement conversion factors were utilized to estimate cost. This approach, i.e., utilizing reimbursement rates as proxies, enables a standardized comparison of the financial implications of operative versus conservative treatments over the study period.
resultsFrom 2014 to 2023, the percentage of fractures managed operatively increased from 13.6% to 17.88%, with a total increase of 4.28% (p-value = 0.001). The reimbursement rate of non-operative treatment increased by 8.56% in treatments without manipulation (CPT: 25560) and a 1.58% increase in treatments with manipulation (CPT: 25565). The reimbursement of operative procedures was essentially unchanged from 2014 to 2024, with an increase ranging from 0.02% (CPT: 25575) to 0.56% (CPT: 25574). From 2014 to 2024, operative treatment had a reimbursement rate ranging from $999.01 to $1349.64, while the rate for conservative treatment ranged from $427.69 to $780.72.
conclusionThe previously established higher reimbursement rate for operative treatment is confirmed by this study. From 2014 to 2023, the higher cost of operative treatment, represented by higher reimbursement rates, and a statistically significant increase in the percentage of patients who underwent operative treatment for pediatric forearm fractures drove up the cost of treatment. The sequelae of an operative preference are largely unknown but include increased treatment costs without evidence-based claims of superior outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.